Prognostic significance of apoptosis regulators in breast cancer

Endocrine-Related Cancer

Volumn 6, Issue 1, 1999, Pages 29-40

  Krajewski, S ^a   Krajewska, M ^a   Turner, B C ^b   Pratt, C ^c   Howard, B ^a   Zapata, J M ^a   Frenkel, V ^d   Robertson, S ^d   Ionov, Y ^a   Yamamoto, H ^a   Perucho, M ^a   Takayama, S ^a   Reed, J C ^a  

^a BURNHAM INSTITUTE   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; BREAST CANCER; CANCER GROWTH; CELL ACTIVITY; HUMAN; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; REGULATORY MECHANISM; REVIEW; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BREAST NEOPLASMS; CARRIER PROTEINS; CASPASES; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; GENES, TUMOR SUPPRESSOR; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; PREGNANCY; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0032943691     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0060029     Document Type: Review

References (78)

1. Aritomi M, Kunishima N, Inohara N, Ishibashi Y, Ohta S & Morikawa K 1997 Crystal structure of rate bcl-xL. Implications for the function of the bcl-2 protein family. Journal of Biological Chemistry 272 27886-27892.
2. Barbareschi M, Caffo O, Veronese S, Leek R, Fina P, Fox S, Bonzanini M, Girlando S, Morelli L, Eccher C, Pezzella F, Doglioni C, Dalla Palma P & Harris A 1996 Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up. Human Pathology 27 1149-1155.
3. Bardelli A, Longati P, Albero D, Goruppi S, Schneider C, Ponzetto C & Comoglio PM 1996 HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. The EMBO Journal 15 6205-6212.
4. Bodrug SE, Aimé-Sempé C, Sato T, Krajewski S, Hanada M & Reed JC 1995 Biochemical and functional comparisons of Mcl-1 and Bcl-2 proteins: evidence for a novel mechanism of regulating Bcl-2 family protein function. Cell Death and Differentiation 2 173-182.
5. Borner C 1996 Diminished cell proliferation associated with the death-protective activity of Bcl-2. Journal of Biological Chemistry 271 12695-12698.
6. Chou J, Matsuo H, Duan H & Wagner G 1998 Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell 94 171-180.
7. Clevenger C, Thickman K, Ngo W, Chang W, Takayama S & Reed J 1997 Role of Bag-1 in the survival and proliferation of the cytokine-dependent lymphocyte lines, Ba/F3 and Nb2. Molecular Endocrinology 11 608-618.
8. Deveraux Q, Takahashi R, Salvesen GS & Reed JC 1997 X-linked IAP is a direct inhibitor of cell death proteases. Nature 388 300-303.
9. Deveraux QL, Reed JC & Salvesen GS 1999 Caspases and their natural inhibitors as therapeutic targets for regulating apoptosis. In Handbook of Experimental Pharmacology -Proteases as Targets for Therapy. Submitted.
10. Elledge R, Green S, Ciocca D, Pugh R, Allred D, Clark G, Hill J, Ravdin P, O'Sullivan J, Martino S & Osborne C 1998 HER-2 expression and response to tamoxifen in estrogen-receptor positive breast cancer. Clinical Cancer Research 4 7-12.
11. 2+ ions. Journal of Cell Biology 143 217-224.
12. Froesch BA, Takayama S & Reed JC 1998 BAG-1L protein enhances androgen receptor function. Journal of Biological Chemistry 273 11660-11666.
13. Gee J, Robertson J, Ellis I, Willsher P, McClelland R, Hoyle H, Kyme S, Finlay P, Blarney R & Nicholson R 1994 Immunocytochemical localization of Bcl-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy. International Journal of Cancer 59 619-628.
14. Grillot DA, Gonzalez-Garcia M, Ekhterae D, Duan L, Inohara N, Ohta S, Seldin MF & Nunez G 1997 Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. Journal of Immunology 158 4750-4757.
15. Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, de la Pompa JL, Kagi D, Khoo W, Potter J, Yoshida R, Kaufman SA, Lowe SW, Penninger JM & Mak TW 1998 Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94 339-352.
16. Haldar S, Negrini M, Monne M, Sabbioni S & Croce CM 1994 Down-regulation of Bcl-2 by p53 in breast cancer cells. Cancer Research 54 2095-2097.
17. Huang Y, Ray S, Reed J, Ibrado A, Tang C, Nawabi A & Bhalla K 1997 Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells. Breast Cancer Research and Treatment 42 73-81.
18. Jäätteelä M, Wissing D, Kokholm K, Kallunki T & Egeblad M 1998 Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO Journal 17 6124-6134.
19. Joensuu H, Pylkkänen L & Toikkanen S 1994 Bcl-2 protein expression and long-term survival in breast cancer. American Journal of Pathology 145 1191-1198.
20. Johnston SRD, MacLennan KA, Sacks NPM, Salter J, Smith IE & Dowsett M 1994 Modulation of Bcl-2 and Ki-67 expression in oestrogen receptor-positive human breast cancer by tamoxifen. European Journal of Cancer 30A 1663-1669.
21. Kapranos N, Karaiosifidi H, Valavanis C, Kouri E & Vasilaros S 1997 Prognostic significance of apoptosis related proteins Bcl-2 and Bax in node-negative breast cancer patients. Anticancer Research 17 2499-2505.
22. Kitada S, Andersen J, Akar S, Zapata JM, Schiffer CA, Takayama S, Krajewski S, Wang H-G, Zhang X, Bullrich F, Croce CM, Rai K, Hines J & Reed JC 1998 Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood 91 3379-3389.
23. Knudson CM, Tung KSK, Tourtellotte WG, Brown GAJ & Korsmeyer SJ 1995 Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270 96-99.
24. Krajewska M, Fenoglio-Preiser CM, Krajewski S, Song K, Macdonald JS, Stemmerman G & Reed JC 1996a Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. American Journal of Pathology 149 1449-1457.
25. Krajewska M, Krajewski S, Epstein JI, Shabaik A, Sauvageot J, Song K, Kitada S & Reed JC 1996b Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. American Journal of Pathology 148 1567-1576.
26. Krajewska M, Moss S, Krajewski S, Song K, Holt P & Reed JC 1996c Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Research 56 2422-2427.
27. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W & Reed JC 1993 Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Research 53 4701-4714.
28. Krajewski S, Bodrug S, Gascoyne R, Berean K, Krajewska M & Reed JC 1994a Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. American Journal of Pathology 145 515-525.
29. Krajewski S, Krajewska M, Shabaik A, Wang H-G, Irie S, Fong L & Reed JC 1994b Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Research 54 5501-5507.
30. Krajewski S, Blomvqvist C, Franssila K, Krajewska M, Wasenius V-M, Niskanen E & Reed JC 1995a Reduced expression of pro-apoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Research 55 4471-4478.
31. Krajewski S, Bodrug S, Krajewska M, Shabaik A, Gascoyne R, Berean K & Reed JC 1995b Immunohistochemical analysis of Mcl-1 protein in human tissues: differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. American Journal of Pathology 146 1309-1319.
32. Krajewski S, James H, Ross J, Blumberg B, Epstein L, Gendelman H, Dewhurst S, Sharer L, Reed J & Gelbard H 1997a Expression of pro- and anti-apoptosis gene products in brains from paediatric patients with HIV-1 encephalitis. Neuropathology and Applied Neurobiology 23 242-253.
33. Krajewski S, Krajewska M, Ehrmann J, Sikorska M, Lach B, Chatten J & Reed J 1997b Immunocytochemical analysis of Bcl-2, Bcl-X Mcl-1, and Bax in tumors of the central and peripheral nervous system. American Journal of Pathology 150 805-814.
34. Krajewski S, Thor AD, Edgerton SM, Moore DH, Krajewska M & Reed JC 1997c Immunohistochemical analysis of Bax and Bcl-2 in p53-immunopositive breast cancers. Clinical Cancer Research 3 199-208.
35. Leek RD, Kaklamanis L, Pezzella F, Gatter KC & Harris AL 1994 Bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. British Journal of Cancer 69 135-139.
36. Li P, Nijhawan D, Budihardjo I, Srinivasula S, Ahmad M, Alnemri E & Wang X 1997 Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91 479-489.
37. Liu R, Takayama S, Zheng Y, Froesch B, G-Q C, Zhang X, Reed JC & Zhang X-K 1997 Interaction of BAG-1 with retinoic acid receptor and its inhibition of retinoic acid-induced apoptosis in cancer cells. Journal of Biological Chemistry 273 16985-16992.
38. Liukkonen T, Lipponen P, Helle M & Jauhiainen K 1997 Immunoreactivity of Bcl-2, p53, and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Urological Research 25 1-7.
39. Matsuzawa S, Takayama S, Froesch B, Zapata JM & Reed JC 1998 p53-inducible human homologue of Drosophila seven oin abstentia (siah) inhibits cell growth by a BAG-1. EMBO Journal 17 2736-2747.
40. Miyashita T & Reed JC 1995 Tumor suppressor p53 is a direct transcriptional activator of human Bax gene. Cell 80 293-299.
41. Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, Yoon HS, Nettesheim D, Changs BS, Thompson CB, Wong S, Ng S & Fesik SW 1996 X-ray and NMR structure of human Bcl-XL, an inhibitor of programmed cell death. Nature 381 335-341.
42. Oltvai Z, Milliman C & Korsmeyer S 1993 Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 609-619.
43. Pan G, O'Rourke K & Dixit VM 1998 Caspase-9, Bcl-XL, and apaf-1 form a ternary complex. Journal of Biological Chemistry 273 5841-5845.
44. Pettaway C 1998 Prognostic markers in clinically localized prostate cancer. Techniques in Urology 4 35-42.
45. Pratt C, Krajewski S, Menard M, Krajewska M, MacCleod H & Reed J 1998 Estrogen withdrawal-induced human breast cancer tumor regression in nude mice is prevented by Bcl-2. FEBS Letters 440 403-408.
46. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC & Perucho M 1997 Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275 967-969.
47. Reed JC 1994 Bcl-2 and the regulation of programmed cell death. Journal of Cell Biology 124 1-6.
48. Reed JC 1996a Balancing cell life and death: Bax, apoptosis, and breast cancer. Journal of Clinical Investigation 97 2403-2404.
49. Reed JC 1996b A day in the life of the Bcl-2 protein: does the turnover rate of Bcl-2 serve as a biological clock for cellular lifespan regulation? Leukemia Research 20 109-111.
50. Reed JC 1997a Bcl-2 family proteins: strategies for overcoming chemoresistance in cancer. In Apoptosis: pharmacological implications and therapeutic opportunities, pp 501-532. Ed SH Kaufmann. San Diego: Academic Press.
51. Reed JC 1997b Double identity for proteins of the Bcl-2 family. Nature 387 773-776.
52. Reed JC 1999 Bcl-2 family proteins: relative importance as determinants of chemoresistance in cancer. In Apoptosis and Cancer Therapy, pp 99-116. Eds JA Hickman & C Dive. Totowa: Humana Press.
53. Reed J & Krajewski S 1998 Apoptosis research: life in the fast lane. DAKO Research Connection 3 6-11.
54. Reed JC, Miyashita T, Takayama S, Wang H, Sato T, Krajewski S, Aime-Sempe C, Bodrug S, Kitada S & Hanada M 1996 BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. Journal of Cellular Biochemistry 60 23-32.
55. Roy N, Deveraux QL, Takashashi R, Salvesen GS & Reed JC 1997 The c-IAP-1 and c-IaP-2 proteins are direct inhibitors of specific caspases. EMBO Journal 16 6914-6925.
56. Sato T, Hanada M, Bodrug S, Irie S, Iwama N, Boise LH, Thompson CB, Golemis E, Fong L, Wang H-G & Reed JC 1994 Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proceedings of the National Academy of Sciences of the USA 91 9238-9242.
57. Schendel SL, Xie Z, Montal MO, Matsuyáma S, Montai M & Reed JC 1997 Channel formation by antiapoptotic protein Bcl-2. Proceedings of the National Academy of Sciences of the USA 94 5113-5118.
58. Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB & Korsmeyer SJ 1995 Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proceedings of the National Academy of Sciences of the USA 92 7834-7838.
59. Shabaik AS, Krajewski S, Burgan A, Krajewska M & Reed JC 1994 Bcl-2 proto-oncogene expression in normal, hyperplastic, and neoplastic prostate tissue. Journal of Urological Pathology 3 17-27.
60. Silvestrini R, Veneroni S, Daidone MG, Benini E, Boracchi P, Mezzetti M, Di Fronzo G, Rilke F & Veronesi U 1994 The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. Journal of the National Cancer Institute 86 499-504.
61. Silvestrini R, Benini E, Veneroni S, Daidone MG, Tomasic G, Squicciarini P & Salvadori B 1996 p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients. Journal of Clinical Oncology 14 1604-1610.
62. Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA & Reed JC 1995 Cloning and functional analysis of BAG-1: a novel Bcl-2 binding protein with anti-cell death activity. Cell 80 279-284.
63. Takayama S, Bimston DN, Matsuzawa S, Freeman BC, Aime-Sempe C, Xie Z, Morimoto RJ & Reed JC 1997 BAG-1 modulates the chaperone activity of Hsp70/Hsc70. EMBO Journal 16 4887-4896.
64. Takayama S, Krajewski S, Krajewska M, Kitada S, Zapata JM, Kochel K, Knee D, Scudiero D, Tudor G, Miller GJ, Miyashita T, Yamada M & Reed JC 1998 Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Research 58 3116-3131.
65. Takayama S, Xie Z & Reed JC 1999 An evolutionary conserved family of Hsp70/Hsc70 molecular chaperone regulators. Journal of Biological Chemistry 274 781-786.
66. Turner B, Krajewska M, Krajewski K, Wang L, Carter D, Takayama S, Kochel K, Glazer P, Haffty B & Reed J 1997 Characterization of the subcellular location of BAG-1 protein in human breast cancer. Breast Cancer Research and Treatment 46 69.
67. Veronese S, Mauri F, Caffo, Scaioli M, Aldovini D, Perrone G, Galligione E, Doglioni C, Dalla Palma P & Barbareschi M 1998 Bax immunohistochemical expression in breast carcinoma: a study with long term follow-up. International Journal of Cancer 79 13-18.
68. Wang H-G & Reed JC 1998 Mechanisms of Bcl-2 protein function. Histology and Histopathology 13 521-530.
69. Wang H-G, Takayama S, Rapp UR & Reed JC 1996 Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proceedings of the National Academy of Sciences of the USA 93 7063-7068.
70. Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG & Youle RJ 1997 Movement of bax from the cytosol to mitochondria during apoptosis. Journal of Cell Biology 139 1281-1292.
71. Yamamoto H, Sawai H & Perucho M 1997 Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Research 57 4420-4426.
72. Yamamoto H, Sawai H, Weber T, Rodriquez-Bigas M & Perucho M 1998 Somatic frameshift mutations in DNA mismatch repair and proapoptosis genes in hereditary nonpolyposis colorectal cancer. Cancer Research 58 997-1003.
73. Zamzami N, Brenner C, Marzo I, Susin S & Kroemer G 1998 Subcellular and submitochondrial mode of action of Bcl-2-like proteins. Oncogene 16 2265-2282.
74. Zapata JM, Krajewski M, Krajewski S, Huang R-P, Takayama S, Wang H-G, Adamson E & Reed JC 1998 Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors. Breast Cancer Research and Treatment 47 129-140.
75. Zeiner M & Gehring U 1995 A protein that interacts with members of the nuclear hormone receptor family: identification and cDNA cloning. Proceedings of the National Academy of Sciences of the USA 92 11465-11469.
76. Zha H, Aime-Sempe C, Sato T & Reed JC 1996 Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. Journal of Biological Chemistry 271 7440-7444.
77. Zhang G, Kimijina I, Abe R, Watanabe T, Kanno M, Hara K & Tsuchiya A 1998 Apoptotic index correlated to Bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers. Anticancer Research 18 1989-1998.
78. Zou H, Henzel WJ, Liu X, Lutschg A & Wang X 1997 Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90 405-413.